Dakota Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Dakota Wealth Management's BIIB Position: Q2 2026 in Review
Dakota Wealth Management increased its Biogen (BIIB) stake by 3.8% in Q2 2026, buying an estimated $333K and bringing the position to 47,326 shares worth $10.2M. The position accounts for 0.2% of the portfolio, ranked #109.
Dakota Wealth Management first reported a position in BIIB in Q3 2018 and has held it in 17 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Dakota Wealth Management held 47,326 shares of Biogen worth $10.2M as of Q2 2026.
- Dakota Wealth Management bought 1,739 Biogen shares in Q2 2026, an estimated $333K.
- Biogen made up 0.2% of Dakota Wealth Management's portfolio in Q2 2026, its #109 holding.
- Dakota Wealth Management first reported a position in Biogen in Q3 2018 and has held it in 17 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.